Company news

Enliven Therapeutics, Inc. news in 2025

Enliven Therapeutics, Inc.'s news releases, calls and decks from 2025, newest first.

View company

Enliven Therapeutics Reports Inducement Grants as Permitted by the Nasdaq Listing Rules

December 10, 2025

Enliven Therapeutics Announces New CEO to Drive Next Phase of Development

December 10, 2025

Enliven Therapeutics Reports Third Quarter Financial Results and Provides a Business Update

November 11, 2025

Correction: Enliven Therapeutics, Inc.

November 11, 2025

Enliven Therapeutics Announces Clinical Data in CML Patients with Atypical Fusion Transcripts at ASH 2025 Annual Meeting

November 2, 2025

Enliven Therapeutics Announces Oral and Poster Presentations at the Society of Hematologic Oncology (SOHO) 2025 Annual Meeting

August 24, 2025

Enliven Therapeutics Announces Closing of Public Offering of Common Stock and Pre-Funded Warrants and Full Exercise of the Underwriters Option to Purchase Additional Shares

June 17, 2025

Enliven Therapeutics Announces Closing of Public Offering of Common Stock and Pre-Funded Warrants and Full Exercise of the Underwriters' Option to Purchase Additional Shares

June 15, 2025

Enliven Therapeutics Announces Updated Positive Data from Phase 1 Clinical Trial of ELVN-001 in CML at EHA 2025 Congress

June 12, 2025

Enliven Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

June 12, 2025

Enliven Therapeutics Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants

June 12, 2025

Enliven Therapeutics to Present at Upcoming Investor Conferences

May 21, 2025

Enliven Therapeutics Reports First Quarter Financial Results and Provides a Business Update

May 13, 2025

Enliven Therapeutics Announces Updated Positive Data from Phase 1 Clinical Trial of ELVN-001 in CML and Oral Presentation at the EHA 2025 Congress

May 13, 2025

Enliven Therapeutics Announces Poster Presentations at the 2025 AACR Annual Meeting

April 1, 2025

Enliven Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides a Business Update

March 12, 2025

Enliven Therapeutics to Present at the TD Cowen 45th Annual Health Care Conference

February 24, 2025

Decks in 2025